Thiazide diuretics lower blood pressure by blocking a specific salt transporter in your kidneys, which causes your body to excrete more sodium and water in urine. But that’s only part of the story. Over time, thiazides also relax blood vessel walls through a separate mechanism, and this vascular effect is likely what keeps blood pressure down with long-term use.
What Happens Inside the Kidney
Your kidneys filter blood and then selectively reabsorb most of the water and salts before they reach your bladder. One key reabsorption point is a structure called the distal convoluted tubule, where a protein called the sodium-chloride cotransporter (NCC) pulls sodium and chloride back into your bloodstream. This transporter handles about 5 to 10 percent of all the salt your kidneys reclaim.
Thiazide diuretics bind to this transporter and shut it down. With the NCC blocked, sodium and chloride stay in the fluid that becomes urine instead of being reabsorbed. Water follows the sodium (water always moves toward higher salt concentrations), so you produce more urine. The net result in the first few weeks is a reduction in total fluid volume in your body, which lowers blood pressure.
The Longer-Term Vascular Effect
After several weeks of thiazide use, your body’s fluid volume largely returns to normal, yet blood pressure stays lower. This puzzled researchers for years. The explanation involves a direct effect on blood vessels that has nothing to do with the kidney transporter thiazides are known for blocking.
Research from the American Heart Association showed that thiazides activate potassium channels in blood vessel walls, specifically large-conductance calcium-activated potassium channels. When these channels open, the smooth muscle cells lining your arteries relax and the vessels widen. This reduces peripheral vascular resistance, the force your heart has to pump against, and keeps blood pressure down even after fluid levels normalize. Notably, this vasodilator effect was confirmed in patients born without a functioning NCC transporter, proving it operates through a completely independent pathway.
Effects on Potassium and Other Electrolytes
One of the most common side effects of thiazides is low potassium. This doesn’t happen at the site where thiazides act, because the NCC transporter moves sodium and chloride without directly involving potassium. Instead, the problem occurs further downstream in the kidney. When thiazides block sodium reabsorption in the distal tubule, more sodium flows to the collecting duct. There, the kidney trades sodium for potassium under the influence of the hormone aldosterone, and that extra sodium delivery means more potassium gets dumped into the urine.
This potassium loss can also shift your blood’s acid-base balance toward a mildly alkaline state, a condition called metabolic alkalosis. The degree of alkalosis with thiazides tends to be less severe than with stronger diuretics like furosemide, because thiazides only affect 5 to 10 percent of sodium reabsorption rather than the 25 percent that loop diuretics target.
Effects on Calcium, Blood Sugar, and Uric Acid
Thiazides reduce the amount of calcium you excrete in urine. The distal tubule and the segment just beyond it actively regulate calcium reabsorption, and thiazide use enhances this process. This is why thiazides are sometimes chosen specifically for people with recurrent calcium kidney stones or osteoporosis risk.
On the less helpful side, thiazides can nudge blood sugar levels upward. The leading explanation ties this back to potassium loss: potassium normally helps stimulate insulin release from the pancreas, so when potassium drops, insulin secretion can falter. Low magnesium levels (another consequence of thiazide use) may compound this. Elevated fatty acids, sympathetic nervous system activation from the blood pressure drop, and direct effects on insulin sensitivity have all been proposed as contributing factors. For most people, this glucose shift is modest, but it can matter if you already have prediabetes or diabetes.
Thiazides also tend to raise uric acid levels. This occurs because the kidneys reabsorb more uric acid when fluid volume decreases, which can occasionally trigger gout in susceptible individuals.
When Thiazides Stop Working: Kidney Function Thresholds
Thiazides need adequate blood flow through the kidneys to reach their target transporter. When kidney function declines below a glomerular filtration rate (GFR) of about 30 mL/min, most thiazides can no longer produce meaningful diuresis at standard doses. This cutoff corresponds roughly to stage 4 chronic kidney disease. At that point, doctors typically switch to a loop diuretic, which acts on a different, higher-capacity part of the kidney. One exception is metolazone, a thiazide-like drug that retains effectiveness even below this GFR threshold.
Chlorthalidone vs. Hydrochlorothiazide
These are the two most commonly prescribed thiazide-type diuretics, and they are not interchangeable. Chlorthalidone is roughly 1.5 to 2 times as potent as hydrochlorothiazide and lasts far longer in the body. Hydrochlorothiazide has a half-life of 6 to 15 hours depending on how long you’ve been taking it, while chlorthalidone’s half-life ranges from 40 to 60 hours. In practical terms, a single dose of chlorthalidone controls blood pressure for 48 to 72 hours with chronic dosing, compared to 16 to 24 hours for hydrochlorothiazide.
The evidence base also differs. The largest and most influential blood pressure trials, including ALLHAT and SHEP, primarily used chlorthalidone. ALLHAT found fewer cardiovascular events, strokes, and heart failure episodes with chlorthalidone compared to an ACE inhibitor, and lower heart failure risk compared to amlodipine. Studies using hydrochlorothiazide have been less consistently positive. Because of chlorthalidone’s longer action and stronger trial data, many experts consider it the preferred choice, though hydrochlorothiazide remains far more commonly prescribed in practice.
Where Thiazides Fit in Blood Pressure Treatment
The 2025 AHA/ACC hypertension guidelines list thiazide-type diuretics as one of four first-line drug classes for treating high blood pressure, alongside calcium channel blockers, ACE inhibitors, and ARBs. Typical starting doses are 12.5 to 25 mg daily for chlorthalidone, 25 to 50 mg daily for hydrochlorothiazide, and 1.25 to 2.5 mg daily for indapamide (another thiazide-like option). These are supported by strong randomized trial evidence for both blood pressure lowering and prevention of cardiovascular events like stroke and heart failure.
Thiazides are often a particularly good fit for older adults with isolated systolic hypertension, people with calcium kidney stones, and patients who need an affordable, once-daily medication. They’re less ideal for people with significantly reduced kidney function, a history of gout, or difficulty maintaining normal potassium levels.